Compare · PG vs PHH
PG vs PHH
Side-by-side comparison of Procter & Gamble Company (PG) and Park Ha Biological Technology Co. Ltd. (PHH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PG and PHH operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- PG carries a market cap of $331.56B.
- Over the past year, PG is down 9.3% and PHH is down 29.0% - PG leads by 19.7 points.
- PG has hit the wire 35 times in the past 4 weeks while PHH has been quiet.
- PG has more recent analyst coverage (25 ratings vs 0 for PHH).
- Company
- Procter & Gamble Company
- Park Ha Biological Technology Co. Ltd.
- Price
- $142.69-1.99%
- $0.38-0.29%
- Market cap
- $331.56B
- -
- 1M return
- -2.56%
- -23.43%
- 1Y return
- -9.33%
- -29.00%
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NYSE
- NASDAQ
- IPO
- 2024
- News (4w)
- 35
- 0
- Recent ratings
- 25
- 0
Procter & Gamble Company
The Procter & Gamble Company provides branded consumer packaged goods to consumers in North and Latin America, Europe, the Asia Pacific, Greater China, India, the Middle East, and Africa. It operates in five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments; and antiperspirants and deodorants, personal cleansing, and skin care products under the Head & Shoulders, Herbal Essences, Pantene, Rejoice, Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.
Latest PG
- Dawn® and Cascade® Team Up with Ann Michael Maye to Make Game Day Cleanup Fast and Easy and Give Fans a Chance to Score a Trip to Super Bowl LXI
- P&G to Webcast Fireside Chat From the Barclays Global Consumer Staples Conference, September 10
- Febreze and Dunkin’® Brew Up a First-Of-Its-Kind Scent Collection
- Tide Expands Free & Gentle Line for the First Time in Over 30 Years with New Light Scented Innovation, Fresh & Gentle
- SEC Form DEFA14A filed by Procter & Gamble Company
- SEC Form DEF 14A filed by Procter & Gamble Company
- Amendment: Chf Rsch, Dev & Innov Officer Aguilar Moses Victor Javier sold $438,991 worth of shares (3,053 units at $143.79), decreasing direct ownership by 6% to 49,511 units (SEC Form 4)
- Olay Launches 'Barrier Bootcamp' With New Repair Serum Body Wash Collection — Your Shower-Powered Workout for Skin Barrier Repair
- SVP - Chief Accounting Officer Janzaruk Matthew W. sold $52,141 worth of shares (359 units at $145.24), decreasing direct ownership by 22% to 1,271 units (SEC Form 4)
- Chf Rsch, Dev & Innov Officer Aguilar Moses Victor Javier sold $438,991 worth of shares (3,053 units at $143.79), decreasing direct ownership by 6% to 49,511 units (SEC Form 4)
Latest PHH
- Park Ha Biological Technology Co., Ltd. Announces Official Approval of Its North American Amazon Store, Launching a New Era of Brand Globalization
- Park Ha Biological Technology Co., Ltd. Announces Membership Application to Personal Care Products Council (PCPC), Aligning the Brand with International Standards and Marking a Strategic Milestone in its Expansion into Amazon North America
- Park Ha Biological Technology Co., Ltd. Announces Cooperation with Amazon to Support Its Entry into the North American Personal Care Sector and Accelerate the Implementation of Its Global Strategy
- Park Ha Biological Technology Co., Ltd. announces strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK) to build an AI-driven ecosystem for the beauty industry.
- Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering
- Park Ha Biological Technology Co., Ltd. Announces Pricing of $2.0 Million Registered Direct Offering
- Park Ha Biological Technology Co., Ltd. announces strategic partnership with Star Plus Legend Group's wholly-owned subsidiary to build an AI-powered skincare and health ecosystem and expand its healthcare reach
- Park Ha Biological Technology Co., Ltd. Announces Closing of a US$2.45 Million Public Offering
- Park Ha Biological Technology Co., Ltd. Announces Pricing of US$2.45 Million Best-Efforts Follow-on Public Offering
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.